Companies accused of recklessly marketing and distributing prescription opioid painkillers are paying roughly $58 billion to settle lawsuits over their role in fueling the addiction crisis. It’s a pot of gold eyed by addiction treatment providers, companies creating the latest opioid-related products, and government officials struggling to balance budgets. Nearly half of that money is…
The resilience of Medicaid lies in its complexity. It has resisted large-scale restructuring because it is interwoven with public and private delivery systems. That same complexity now demands a different kind of legal engagement. Medicaid is no longer a silo, but a system-defining platform. The post The Medicaid Reckoning: Era of Fiscal and Policy Flux…
When demand fluctuates, even slightly, the margin for error becomes clear – highlighting the urgent need for greater efficiency to meet rising procedural demand. The post What Seasonal Pressures Continue to Teach Us About the Fragility of the US Surgical System appeared first on MedCity News.
Happy Health’s $75 million round was from ARCH Venture Partners and OpenLoop. The post Happy Health Snags $75M to Support Home-Based Care appeared first on MedCity News.
Medical educators and health professionals warn that new federal student loan caps in President Donald Trump’s tax cut law could make it more expensive for many people to become doctors and could exacerbate physician shortages nationwide. And, they warn, the economic burden will steer many medical students to lucrative specialties in more affluent, urban areas…
Partnership with ESO provides nearly 4,000 first responders along the Wasatch Front with access to patient care outcomes
Ambience Healthcare closed a $243 million Series C funding round, bringing its valuation to $1.25 billion. The startup, which offers an AI-powered platform for clinical documentation and coding, aims to reduce clinician burnout by automating time-consuming administrative tasks across a wide range of specialties. The post Ambience Healthcare Gains Unicorn Status & Snags $243M appeared…
Honoring Tom Racobaldo: Crothall CEO to Retire After Decades of Leadership In 1979, Tom Racobaldo refinished hospital floors and cleaned patient rooms as a Crothall management trainee. Six months later, he received his first assignment: managing a 50-bed hospital with 10 employees in northeast Philadelphia. Forty-six years later, Racobaldo will retire as Crothall’s chief executive officer. Well-known for his humility, Racobaldo will complete nearly a half-century in the business at the top…
Bristol Myers Squibb is turning to the prime-editing technology of Prime Medicines for the R&D of new cell therapies for cancer and immunology. The pharma giant is paying $110 million up front to begin the collaboration. The post Gene-Editing Biotech Prime Medicine Strikes Up Cell Therapy R&D Alliance With Bristol Myers Squibb appeared first on…
This KFF analysis demonstrates the impact exclusion of Planned Parenthood from Medicaid and the Title X funding freeze may have low-income and uninsured individuals who get their family planning care at Planned Parenthood.